MERIT MEDICAL SYSTEMS INC (MMSI) earnings date
Feb 24, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 12 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 29, 2026 | after close | 29 | 8-K |
| Q2 FY2026 | Thu, Jul 30, 2026 | after close | 30 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | after close | 30 | 8-K |
| Q4 FY2025 | Tue, Feb 24, 2026 | after close | 55 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | after close | 30 | 8-K |
| Q2 FY2025 | Wed, Jul 30, 2025 | after close | 30 | 8-K |
| Q1 FY2025 | Thu, Apr 24, 2025 | after close | 24 | 8-K |
| Q4 FY2024 | Tue, Feb 25, 2025 | after close | 56 | 8-K |
What they guided beta
| Q3 FY2026 | "EX-99.1 2 mmsi-ex99d1.htm EX-99.1 Exhibit 99.1 Contacts: PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS THIRD QUARTER 2026 RESULTS: DELIVERS 9% ORGANIC CONSTANT CURRENCY REVENUE GROWTH AND RAISES FULL-YEAR 2026 GUIDANCE Financial Highlights†" exhibit |
| Q3 FY2026 | "Aronson 1 continued: “We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year." exhibit |
| Q3 FY2026 | "Fiscal Year 2026 Financial Guidance Based upon the information currently available to Merit’s management, for the twelve-month period ending December 31, 2026, absent the potential impact of trade policies and related actions implemented by the U.S. and other countries subsequent to today’s date, material acquisitions, non-recurring transactions or other factors beyond Merit’s current expectations, Merit anticipates the following financial results: Revenue and Earnings Guidance* Updated Guidance Prior Guidance (2) Year Ending % Change Year Ending % Change Financial Me" exhibit |
| Q3 FY2026 | "(2) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on July 30, 2026." exhibit |
| Q3 FY2026 | "Merit’s financial guidance for the year ending December 31, 2026 is subject to risks and uncertainties identified in this release and Merit’s filings with the SEC." exhibit |
| Q2 FY2026 | "EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 Contacts: PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS SECOND QUARTER 2026 RESULTS AND UPDATES FULL-YEAR 2026 GUIDANCE Financial Highlights†" exhibit |
| Q2 FY2026 | "“We experienced improving revenue growth trends across our global business in Q2, as expected, with notable strength in sales to customers in the U.S. which increased 10% year-over-year, well ahead of our expectations." exhibit |
| Q2 FY2026 | "Aronson continued: “We have increased our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first half of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year." exhibit |
| Q2 FY2026 | "Fiscal Year 2026 Financial Guidance Based upon the information currently available to Merit’s management, for the twelve-month period ending December 31, 2026, absent the potential impact of trade policies and related actions implemented by the U.S. and other countries subsequent to today’s date, material acquisitions, non-recurring transactions or other factors beyond Merit’s current expectations, Merit anticipates the following financial results: Revenue and Earnings Guidance* Updated Guidance Prior Guidance (2) Year Ending % Change Year Ending % Change Financial Me" exhibit |
| Q2 FY2026 | "(2) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on April 30, 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MMSI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MMSI
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/MMSI/"><img src="https://veritasdata.dev/embed/MMSI.svg" alt="MMSI earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/MMSI/)
Script
<script async src="https://veritasdata.dev/embed/MMSI.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MMSI"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.